SomaLogic, Inc.
NASDAQ:SLGC
2.1 (USD) • At close January 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 97.666 | 81.626 | 55.889 | 32.187 |
| Cost of Revenue
| 43.364 | 33.463 | 22.614 | 49.72 |
| Gross Profit
| 54.302 | 48.163 | 33.275 | -17.533 |
| Gross Profit Ratio
| 0.556 | 0.59 | 0.595 | -0.545 |
| Reseach & Development Expenses
| 73.444 | 43.496 | 30.749 | 32.502 |
| General & Administrative Expenses
| 153.119 | 77.271 | 36.682 | 33.324 |
| Selling & Marketing Expenses
| 3.5 | 0.7 | 0.2 | 0.1 |
| SG&A
| 156.619 | 77.971 | 36.882 | 33.424 |
| Other Expenses
| 1.945 | 0.681 | 0 | 0 |
| Operating Expenses
| 230.063 | 121.467 | 67.631 | 33.989 |
| Operating Income
| -175.761 | -73.304 | -34.356 | -50.957 |
| Operating Income Ratio
| -1.8 | -0.898 | -0.615 | -1.583 |
| Total Other Income Expenses Net
| 65.887 | -14.243 | -18.659 | -6.045 |
| Income Before Tax
| -109.874 | -87.547 | -53.015 | -57.002 |
| Income Before Tax Ratio
| -1.125 | -1.073 | -0.949 | -1.771 |
| Income Tax Expense
| -0.717 | -1.245 | 18.338 | 0 |
| Net Income
| -109.157 | -86.302 | -71.353 | -57.002 |
| Net Income Ratio
| -1.118 | -1.057 | -1.277 | -1.771 |
| EPS
| -0.59 | -0.63 | -0.39 | 0 |
| EPS Diluted
| -0.59 | -0.63 | -0.39 | 0 |
| EBITDA
| -167.712 | -73.079 | -31.303 | -47.8 |
| EBITDA Ratio
| -1.717 | -0.895 | -0.56 | -1.485 |